Phreesia Inc (PHR)
22.32
+0.06
(+0.27%)
USD |
NYSE |
May 03, 16:00
22.33
+0.01
(+0.04%)
After-Hours: 20:00
Phreesia Enterprise Value: 1.174B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.174B |
| May 02, 2024 | 1.171B |
| May 01, 2024 | 1.100B |
| April 30, 2024 | 1.085B |
| April 29, 2024 | 1.091B |
| April 26, 2024 | 1.078B |
| April 25, 2024 | 1.069B |
| April 24, 2024 | 1.153B |
| April 23, 2024 | 1.220B |
| April 22, 2024 | 1.179B |
| April 19, 2024 | 1.139B |
| April 18, 2024 | 1.191B |
| April 17, 2024 | 1.222B |
| April 16, 2024 | 1.213B |
| April 15, 2024 | 1.198B |
| April 12, 2024 | 1.245B |
| April 11, 2024 | 1.258B |
| April 10, 2024 | 1.229B |
| April 09, 2024 | 1.254B |
| April 08, 2024 | 1.206B |
| April 05, 2024 | 1.144B |
| April 04, 2024 | 1.171B |
| April 03, 2024 | 1.202B |
| April 02, 2024 | 1.206B |
| April 01, 2024 | 1.217B |
| Date | Value |
|---|---|
| March 28, 2024 | 1.265B |
| March 27, 2024 | 1.291B |
| March 26, 2024 | 1.252B |
| March 25, 2024 | 1.213B |
| March 22, 2024 | 1.214B |
| March 21, 2024 | 1.245B |
| March 20, 2024 | 1.281B |
| March 19, 2024 | 1.223B |
| March 18, 2024 | 1.209B |
| March 15, 2024 | 1.255B |
| March 14, 2024 | 1.194B |
| March 13, 2024 | 1.232B |
| March 12, 2024 | 1.227B |
| March 11, 2024 | 1.274B |
| March 08, 2024 | 1.316B |
| March 07, 2024 | 1.361B |
| March 06, 2024 | 1.326B |
| March 05, 2024 | 1.324B |
| March 04, 2024 | 1.326B |
| March 01, 2024 | 1.323B |
| February 29, 2024 | 1.310B |
| February 28, 2024 | 1.340B |
| February 27, 2024 | 1.333B |
| February 26, 2024 | 1.346B |
| February 23, 2024 | 1.281B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
458.61M
Minimum
May 11 2022
3.439B
Maximum
Nov 08 2021
1.470B
Average
1.207B
Median
Feb 25 2022
Enterprise Value Benchmarks
| Teladoc Health Inc | 2.609B |
| American Shared Hospital Services | 26.35M |
| Novo Integrated Sciences Inc | 12.29M |
| Astrana Health Inc | 1.458B |
| Cryo-Cell International Inc | 81.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.65M |
| Revenue (Quarterly) | 95.00M |
| Total Expenses (Quarterly) | 124.58M |
| EPS Diluted (Quarterly) | -0.55 |
| Gross Profit Margin (Quarterly) | 66.56% |
| Profit Margin (Quarterly) | -32.26% |
| Earnings Yield | -11.25% |
| Normalized Earnings Yield | -11.25 |